Plasma Concentrations of Contezolid and Its Efficacy and Safety in Elderly Patients with Multidrug-Resistant Tuberculosis and Renal Insufficiency-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Plasma Concentrations of Contezolid and Its Efficacy and Safety in Elderly Patients with Multidrug-Resistant Tuberculosis and Renal Insufficiency

Published:2024-07 Issue: Volume:Volume 17 Page:3047-3056
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Ma Xiaoqing,Zhang Ruoying,Cai Xinjun,Lang Yuying,Wang Huaichong,Li Jinmeng^ORCID

Publisher

Informa UK Limited

Reference20 articles.

1. World Health Organization. Global Tuberculosis Report 2023. Geneva: World Health Organization; 2023.

2. Chinese Medical Association Tuberculosis Branch. Expert consensus on the treatment of multi-drug resistant and rifampicin-resistant tuberculosis in China (2019). Chin J Tuberc Respir. 2019;42(10):733–749.

3. Update of drug-resistant tuberculosis treatment guidelines: A turning point

4. World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP